fujifilm balansCD

FUJIFILM Irvine Scientific launches HEK293 feed, specifically designed for viral vector production

FUJIFILM Irvine Scientific, a world leader in the development and manufacture of serumfree and chemically defined cell culture media for bioproduction and cell therapy manu-facturing, has introduced its BalanCD HEK293 Viral Feed. The chemically defined, nutrient-based HEK293-specific feed medium is designed to boost adeno-associated viral vector (AAV) production for gene therapy applications and viral vector-based […]

RoboCell

Thermo Fisher Scientific partners with Celltrio to introduce fully automated cell line culturing platform

Thermo Fisher Scientific, the world leader in serving science, and Celltrio, a leading manu­facturer of robotics-based solutions for the life sciences industry, have announced their collaboration to bring a fully automated cell culture system to biotherapeutics customers.

isopick

iotaSciences unveils isoPick single-cell picker

iotaSciences, a spin-out from Oxford University in the field of single-cell handling solutions has completed the development for its newly built single-cell picker instrumentation isoPick. isoPick represents a powerful addition to iotaSciences´ existing product portfolio for single-cell handling solutions based on its proprietary fluid-shaping technology. The product portfolio comprises instruments for automatic isolation, feeding and […]

Precisa Balances 520 PT Range

Precisa Gravimetrics receives EU/OIML/UKCA approval for 520 series balance

Precisa Gravimetrics has successfully passed the EU/OIML and UKCA certification for their 520 PT and PB analytical and precision balances, designed and manufactured in Switzerland.

mimetas

MIMETAS launches ready-to-use 3D adult stem cell organoid tubules

MIMETAS, a leading company in the field of organ-on-a-chip-based disease models, has launched its Adult Stem Cell (ASC)-derived tubular organoids in an assay-ready format. As part of its OrganoReady product line, MIMETAS offers two organoid-based products: ASC-derived Colon and Kidney Organoid tubules.

Scherm­afbeelding 2023 03 23 om 19.39.43 e1679596862931

Ziath releases new version of DP5 Network application for remote sample management

Ziath has launched a new version of their popular DP5 Network application that enables tube barcode readers and scanners to be remote controlled from a smart phone or tablet via a Wi-Fi connection.

ELISA microplate automat e1679596562415

EUROIMMUN develops ELISAs for detection of anti-CCHFV antibodies for acute outbreak support

Crimean-Congo haemorrhagic fever (CCHF) is a life-threatening tick-borne viral disease which is included in the World Health Organisation priorities for research and product development for early diagnostics. Since there is no CCHF vaccine available, management of outbreaks relies on rapid identification of cases and appropriate infection control measures.

Owlstone logo

Owlstone partners with Bicycle Therapeutics to develop antigen-targeted EVOC Probes for early cancer detection

Owlstone Medical, the global leader in Breath Biopsy for applications in early disease detection and precision medicine, has entered into a Research Agreement with Bicycle Therapeutics, a biotechnology company pioneering a new and differentiated class of therapeutics based on its proprietary bicyclic peptide (Bicycle) technology.

Beckman Coulter bacteria

Beckman Coulter and MeMed to expand access to host immune response diagnostic to distinguish between bacterial and viral infections

Beckman Coulter Diagnostics, a global leader in clinical diagnostics, and MeMed, a leader in the emerging field of advanced host-response technologies, have established a strategic partnership to jointly develop and commercialize the MeMed BV test, a host immune response diagnostic that is able to distinguish between bacterial and viral infections for use on the Access […]

Exothera Darren Leva

Exothera appoints Darren Leva as Chief Business Officer

Exothera, a full-service Contract Development and Manufacturing Organization (CDMO) specialized in gene therapy, vaccines, and oncolytic viruses, has appointed Darren Leva as Chief Business Officer. Darren’s extensive commercial experience in biotherapeutics CDMOs will further extend Exothera’s business and commercial capability across existing and brand-new markets.